Vitamin D Supplementation for Premature Infants
What You Need to Know Before You Apply
What is the purpose of this trial?
The objective of the study is to compare supplementation with vitamin D at 800 IU/day to usual care for the first 28 days after birth with respect to 25 (OH) vitamin D levels and indicators of likely or plausible effects of vitamin D supplementation on the function or structure of the lung, bones, immune system, and brain in extremely premature (EP) infants who are \<28 weeks gestational age (GA) or \<1000 grams of birth weight (BW). The study results will be analyzed as intention to treat Bayesian analyses (Frequentist analyses will also be performed).
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications.
Is vitamin D supplementation safe for premature infants?
How does the drug Vitamin D3 supplementation for premature infants differ from other treatments?
What data supports the effectiveness of the drug 800 IU/day vitamin D supplementation for premature infants?
Research shows that early supplementation with 800 IU of vitamin D is effective and safe for very low birth weight infants, helping to improve their vitamin D levels. Another study found that even lower doses of vitamin D (500 IU) increased vitamin D levels in premature infants, suggesting that 800 IU could be even more effective.13111213
Who Is on the Research Team?
Sunil Jain, MD
Principal Investigator
The University of Texas Medical Branch
Are You a Good Fit for This Trial?
This trial is for very premature infants born at less than 28 weeks or weighing under 1000 grams. It's not for babies with conditions affecting vitamin D absorption, like cystic fibrosis, those too sick where intensive care isn't justified, with congenital infections, over 32 weeks gestation, or with major birth defects.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Infants receive either vitamin D supplementation or placebo for the first 28 days after birth
Follow-up
Participants are monitored for growth, neurodevelopment, and respiratory outcomes
Extended Follow-up
Monitoring of respiratory support and neurodevelopmental outcomes
What Are the Treatments Tested in This Trial?
Interventions
- 800 IU/day vitamin D supplementation with feedings in the first 28 days after birth
- Placebo
- Usual Care
800 IU/day vitamin D supplementation with feedings in the first 28 days after birth is already approved in European Union, United States, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor